About Xsensio
Xsensio is a company based in Lausanne (Switzerland) founded in 2014. Xsensio has raised $11.55 million across 11 funding rounds from investors including Mayo Clinic, European Union and EIC Fund. Xsensio offers products and services including Lab-on-Skin Sensing Platform and Sensing Chip. Xsensio operates in a competitive market with competitors including InvenSense, Paragraf, Epicore Biosystems, Nix and mCube, among others.
- Headquarter Lausanne, Switzerland
-
Sectors
TechnologyHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Xsensio Sa
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$11.55 M (USD)
in 11 rounds
-
Latest Funding Round
$7 M (USD), Series A
Mar 02, 2026
-
Investors
Mayo Clinic
& 9 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Xsensio
Xsensio offers a comprehensive portfolio of products and services, including Lab-on-Skin Sensing Platform and Sensing Chip.
Provides real-time biochemical monitoring for patient health detection.
Enables continuous tracking of biomarkers in various healthcare settings.
People of Xsensio
Unlock access to complete
Unlock access to complete
Advisor Team
2 people
R Team
1 people
Leadership Team
1 people
Co Team
1 people
Project Team
1 people
Chairman Team
1 people
Unlock access to complete
Funding Insights of Xsensio
Xsensio has successfully raised a total of $11.55M across 11 strategic funding rounds. The most recent funding activity was a Series A round of $7 million completed in March 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Xsensio
Xsensio has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include Mayo Clinic, European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Seed and early-stage startups are invested in by Privilege Ventures.
|
Locked | Locked | Locked | |
|
Grants and loans are provided by FIT for innovative startups.
|
Locked | Locked | Locked |
Investor details for Xsensio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Xsensio
Investment portfolio details for Xsensio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Xsensio
Detailed financials for Xsensio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Xsensio Comparisons
Peer comparison for Xsensio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Xsensio
Xsensio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as InvenSense, Paragraf, Epicore Biosystems, Nix and mCube, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
MotionTracking sensor system on chips with integrated motion and sound solutions
|
|
| Locked | Locked | Locked |
Graphene-based magnetic sensors are developed using proprietary processes.
|
|
| Locked | Locked | Locked |
Wearable sweat-based microfluidic sensing systems are provided for health monitoring.
|
|
| Locked | Locked | Locked |
Sweat-based biosensors are provided for body hydration monitoring.
|
|
| Locked | Locked | Locked |
Delivers comprehensive MEMS motion sensor solutions for smart and wearable devices.
|
|
| Locked | Locked | Locked |
Mixed-signal ASICs for SteamVR sensor arrays are developed and produced.
|
Detailed competitors of Xsensio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Xsensio
Complete news archive for Xsensio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Xsensio
Xsensio was founded in 2014.
Xsensio is headquartered in Lausanne, Switzerland. It is registered at Lausanne, Vaud, Switzerland.
Xsensio is a funded company, having raised a total of $11.55M across 11 funding rounds to date.
Xsensio was founded in 2014 in Lausanne, Switzerland, as a provider in the wearable biosensor sector. Nanotechnology-based sensors are produced to gather data on electrolytes, metabolites, small molecules, and proteins from the skins surface. A companion mobile app is offered for parameter monitoring and sensor customization. Operations focus on connected health monitoring technologies within the biotech industry.
Xsensio's top competitors include Nix, Paragraf and Epicore Biosystems.
Xsensio offers Lab-on-Skin Sensing Platform and Sensing Chip.
Xsensio has 10 investors. Key investors include Mayo Clinic, European Union, EIC Fund, Privilege Ventures, and DART Ventures.